L-arginine metabolism in breast cancer: mechanisms and therapeutic targets - Top-Institutions - MDSpire

L-arginine metabolism in breast cancer: mechanisms and therapeutic targets

  • By

  • Antonia Röglin

  • Rainer Böger

  • Juliane Hannemann

  • June 12, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    The University of Texas MD Anderson Cancer Center
    The University of Texas MD Anderson Cancer Center

    Houston, Texas

    Key Differentiators

    • Oncology
    • Cancer Metabolism

  • #2

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, New York

    Key Differentiators

    • Oncology
    • Cancer Metabolism

  • #3

    Institut Curie
    Institut Curie

    Paris, France

    Key Differentiators

    • Oncology
    • Breast Cancer

  • #4

    Swedish Cancer Institute
    Swedish Cancer Institute

    Seattle, Washington

    Key Differentiators

    • Oncology
    • Breast Cancer

  • #5

    Cancer and Leukemia Group B
    Cancer and Leukemia Group B

    Chicago, Illinois

    Key Differentiators

    • Oncology
    • Clinical Trials

Original Source(s)

L-arginine metabolism in breast cancer: mechanisms and therapeutic targets

  • by Antonia Röglin, Rainer Böger, Juliane Hannemann

  • June 12, 2026

Related Content

Nucleo-mitochondrial asymmetry profiles the proliferative engine and spatial niche reconstruction in clear cell renal cell carcinoma

Who Decides How AI Enters Pathology?

Liron Pantanowitz explains why validation, leadership, and real-world use matter more than performance metrics

Editorial: Importance of quality assurance in radiation oncology clinical trials